Bionano Genomics, Inc. (BNGO)
收市後：
- InvestorPlace
3 Contrarian Investments to Make Now for Massive Upside Potential
Many investors abandon highly promising shares with little chance of failing. The phenomenon has been exacerbated by overdone fears about elevated interest rates. Short sellers often believe that elevated rates will crush indebted, money-losing firms, regardless of their potential. These short sellers put huge downward pressure on small companies that are still in the red and have some debt. As their stock prices sink, many other investors also avoid buying their shares. As a result, the stocks
- Insider Monkey
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript March 5, 2024 Bionano Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.96 EPS, expectations were $-0.87. Bionano Genomics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […]
- Motley Fool
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
BNGO earnings call for the period ending December 31, 2023.
